UK Trade Performance
Paul Girvan Excerpts(7 months, 3 weeks ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Kemi Badenoch
He is shaking his head. In answer to my hon. Friend’s question, we were often told that we would never be able to get those 73 trade deals—we were mocked—and that nobody would sign any deals with the UK that were like what we had in the EU. We got 73 done, and many of them we have actually improved on. We in this House must remind people that we have done much good; they may forget. People live in the moment, and we have to remind them of our record—and this is a record we should be proud of.
Paul Girvan (South Antrim) (DUP)
As much as we welcome the good figures that have been produced, Northern Ireland still suffers from not having full access to the trade deals that the United Kingdom has struck throughout the world with 70 countries. What measures would ensure that we can take advantage of those deals and get rid of the injustice of the protocol and the difficulties that it causes businesses in Northern Ireland?
Kemi Badenoch
We have been doing a lot in Northern Ireland to increase investment and make up for any shortfall, whether through our trade deals or otherwise. The Windsor framework, for example, is one thing that the Prime Minister has worked on to iron out some of those issues. We are looking at where Northern Ireland can exploit the benefits of being part of both the EU single market and the UK single market, which is a unique position. We know that there are some areas in which things are not exactly the same as in GB, but we can look individually in specific trade deals at what we can do. In services, for example, that should not be an issue; we really see the difference in goods. We can do a lot more and we continue to work on that.
Excess Death Trends
Paul Girvan Excerpts(11 months ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Abena Oppong-Asare (Erith and Thamesmead) (Lab)
It is a pleasure, as always, to serve under your chairship, Sir Gary. I congratulate the hon. Member for North West Leicestershire (Andrew Bridgen) on securing this important debate on trends in excess mortality. I also congratulate all hon. Members who have spoken in this lively debate.
The phrase “excess deaths” refers to the difference between the actual registered number of deaths, and the expected number of deaths, based on data from previous years. Recording and understanding such trends is important for any Government of this country, because through that lens we discover areas of growing irregular activity, and we can use that information to tackle issues and improve the lives of our families, our constituents and everyone in this country.
It is sad that excess deaths appear to have increased in recent years. Although there is a range of estimates from different bodies, they all point to an increasing trend. Life expectancy in the UK has also fallen to its lowest level in a decade. Male life expectancy is down 38 weeks from its pre-pandemic peak, and female life expectancy is down 23 weeks. Those worrying trends reinforce the need for us to understand what is happening and what we can do to turn them around.
However, it is important to tackle the claim by the hon. Member for North West Leicestershire that there is a causal link between the covid-19 vaccines and excess deaths in this country.
Abena Oppong-Asare
I am afraid I have limited time.
The Opposition have stated clearly, and I confirm again, that we believe vaccines are the most effective public health intervention in relation to coronavirus and health in general. It is clear from extensive independent research that the covid-19 vaccines have been and continue to be extremely successful at preventing deaths. Sadly, there have been extremely rare cases of people suffering side effects that are possibly linked to the vaccine, but the data does not suggest that there is a link between that and the large increase in excess mortality in recent years. However, when serious side effects do occur, it is right that individuals and their families should have access to the vaccine damage payment. I encourage anyone who has a side effect from any vaccine to use the yellow card system and to report the side effect to their general practitioner.
It is wrong, however, to consistently link the observed excess deaths to covid-19 vaccines. Like my right hon. Friend the Member for Knowsley (Sir George Howarth), I have concerns that making that link not only stokes fear and misinformation, but distracts the public conversation away from other health concerns of critical importance.
The Parliamentary Under-Secretary of State for Health and Social Care (Maria Caulfield)
It is a pleasure to serve under your chairmanship, Sir Gary. I thank the hon. Member for North West Leicestershire (Andrew Bridgen) for securing this important debate. We have had a number of debates; I responded very briefly to his Adjournment debate in October. I acknowledge that he is absolutely correct that there is an increase in excess deaths. We take that very seriously; I take that seriously as a Minister, and from the point of view of my clinical background.
To echo the thoughts of many hon. Members around lessons to be learned from the covid period, I too, as Minister with responsibility for pandemic preparedness, would like answers and advice on the impacts of lockdowns, face masks and the timings of vaccine roll-outs, so that those can be taken into consideration for any future pandemic. Although the inquiry is independent, a focus on those issues would be extremely helpful to me, as Minister.
Maria Caulfield
Not for the moment; let me respond to as many points from hon. Members as I can.
There is an increase in excess deaths. A number of factors contribute to that. We take that seriously, and monitor it constantly. Looking at the past year, for example, there was a high flu prevalence last winter, when there were still ongoing challenges relating to instances of covid-19 and a strep A outbreak, particularly among children. Those had an impact. Statistics from the Office for Health Improvement and Disparities showed that last year, there were almost 26,400 excess deaths in England, and of those excess deaths, 7,300 were due to acute respiratory infections, including flu and pneumonia.
Last winter, the number of positive tests for flu peaked at 31.8%—the highest figure in the last six years. There are schools of thought on that; one is that when people were locked down, they were not exposed to flu for a couple of years, so their immune systems struggle to cope. We have learned those lessons, and that is why, this year, we have brought forward our flu vaccination programme. We have successfully vaccinated over 17.6 million people since the campaign started in September. It is still early in the winter season, but—touch wood—we are seeing fewer admissions from flu and covid than we did last year. We are learning lessons from those excess deaths.
There are also excess deaths from cardiovascular diseases; that was pointed out during the debate. The figure is 6% higher than expected in England, with almost 13,500 excess deaths attributed to cardiovascular disease. Lockdown did have an impact on that. We know that people were not getting their cholesterol tested or their blood pressure checked, and were still smoking. Antihypertensives and statins were not being prescribed. Again, we have taken action. As my hon. Friend the Member for South West Bedfordshire (Andrew Selous) pointed out, we are supporting local authorities to resume normal NHS healthcare checks; between April and June last year, the highest number of checks were offered since the programme began in 2013. We are investing £17 million in innovative new digital health checks, to be rolled out this spring, that will deliver an additional 1 million checks in the first four years. We have a £10 million pilot to deliver up to 150,000 cardiovascular disease checks in the workplace, with free blood pressure checks being rolled out in community pharmacies to people over 40, and we are investing £645 million to include blood pressure checks in our community pharmacy facilities. That is in addition to the work the Prime Minister announced on a smoke-free generation, which will be debated further, through which we want to see smoking rates further reduce.
I turn to the elephant in the room—covid vaccines—because the hon. Member for North West Leicestershire and other hon. Members have raised concerns about their safety. It is true that Office for National Statistics data, published only in August, shows that people who have had a covid-19 vaccine have a lower mortality rate than those who have not been vaccinated. My hon. Friend the Member for Bosworth (Dr Evans) and the hon. Member for North West Leicestershire are absolutely correct that a high number of people who were vaccinated appear in the excess death population, but when 93.6% of the population have had at least one dose of a covid vaccine, there will be a high number of vaccinated people in the excess death numbers. That is prevalence, not causality. It is important that we look at the causes of excess deaths and tackle them.
Maria Caulfield
I do not have those figures on me, but I will be very happy to write to the hon. Lady with them. I am not saying that the rate is higher if people are vaccinated but that a high number of vaccinated people appear in the excess death figures because 93.6% of the population were vaccinated. That does not link to causality; it shows a high prevalence instead.
Paul Girvan
On that very point, during the public inquiry, should greater importance not have been placed on investigating the excess deaths, as opposed to delaying that part of the inquiry?
Maria Caulfield
The public inquiry is independent, and the Government are under heavy scrutiny from it. It is not for me to say how the inquiry should be conducted. As a Government, we are looking at the causes of excess deaths and introducing, where we can, urgent measures to reverse that increase as quickly as possible.
No vaccine or medicine—even simple paracetamol—is completely risk free, but we have systems in place to continually monitor the safety of our medicines. For example, in April 2021, following concerns raised through the yellow card system or by GPs or clinicians, the MHRA reacted to rare cases of concurrent thrombosis and thrombocytopenia following the AZ vaccine. That resulted in actions, with adults under 30 not offered the vaccine any further. In May of that year, that was extended to adults under 40. Where there is concern, we will take action and take recommendations from bodies like the MHRA to make sure that those vaccines are as safe as they can be.